Oncologix Tech, Inc. Share Price Other OTC
Equities
OCLG
US68230M2098
Investment Holding Companies
Sales 2013 | 0.24 20.34 | Sales 2014 | 3.68 306.19 | Capitalization | 8L 6.31Cr |
---|---|---|---|---|---|
Net income 2013 | - 0 | Net income 2014 | -10L -8.33Cr | EV / Sales 2013 | 87,16,069 x |
Net Debt 2013 | 13.27L 11Cr | Net Debt 2014 | 18.95L 16Cr | EV / Sales 2014 | 7,21,342 x |
P/E ratio 2013 |
-1.03
x | P/E ratio 2014 |
-0.47
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25/21/25 |
Nikole Jessie
IRO | Public Communications Contact | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25/21/25 |
1st Jan change | Capi. | |
---|---|---|
+190.94% | 696.01Cr | |
+2.14% | 98Cr | |
+41.91% | 87Cr | |
+26.98% | 83Cr | |
+1.72% | 66Cr | |
+5.92% | 64Cr | |
-.--% | 60Cr | |
+3.61% | 50Cr | |
-.--% | 50Cr |